Latest Articles
- Influenza 2010–2011: Lessons from the 2009 pandemic
The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.
- Intracerebral hemorrhage: Pick your poison
Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.
- When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.
- What’s new in treating older adults?
Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.
- Preventing clots: Don’t let the complex overshadow the simple
Although we often approach anticoagulation therapy with a confidence born of familiarity, it is not for the faint of heart.
Approach to a low TSH level: Patience is a virtueConfronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
- How to prevent glucocorticoid-induced osteoporosis (August 2010)
Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).
- Palmoplantar eruption
A 38-year-old woman with a history of episodes of arthritis presents with pustules on the palms and on the soles of her feet. What is the most likely diagnosis?
- Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid?
Efforts to modify the course of Alzheimer disease have, until now, been based on altering the production or clearance of beta-amyloid. Results have been disappointing.